Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The stimulation of antral motility by erythromycin is attenuated by hyperglycemia

Identifieur interne : 00BF26 ( Main/Exploration ); précédent : 00BF25; suivant : 00BF27

The stimulation of antral motility by erythromycin is attenuated by hyperglycemia

Auteurs : C. K Rayner [Australie] ; Y.-C Su [Australie] ; S. M Doran [Australie] ; K. L Jones [Australie] ; C. H Malbert [France] ; M. Horowitz [Australie]

Source :

RBID : ISTEX:1AABB8E93B47CD8CF212597BA37A30ACA32F387B

Descripteurs français

English descriptors

Abstract

Abstract: OBJECTIVE:Diabetic gastroparesis is usually treated with prokinetic drugs, of which the most potent, when given intravenously during euglycemia, is erythromycin. Recent studies have demonstrated that the gastrokinetic effects of erythromycin are attenuated by hyperglycemia. The aim of this study was to determine whether the effects of erythromycin on antropyloroduodenal motility, including the organization of antral pressure waves, are modified by hyperglycemia.METHODS:A total of eight healthy male volunteers (median age 24 yr) were studied on 2 days each in randomized order. A manometric assembly, incorporating six antral, two pyloric, and seven duodenal sideholes and a pyloric sleeve sensor, was positioned with the sleeve spanning the pylorus. The blood glucose concentration was stabilized at about 5 mmol/L (euglycemia) or 15 mmol/L (hyperglycemia). After 30 min (T = 0), an intraduodenal lipid infusion (1.5 kcal/min) was commenced and continued until the end of the study. At T = 20 minutes, erythromycin (200 mg) as the lactobionate was infused intravenously over 20 min, followed by 100 mg over the next 40 min.RESULTS:Intravenous erythromycin increased the amplitude of antral waves during intraduodenal lipid infusion at both blood glucose concentrations (p < 0.01 for euglycemia and p < 0.05 for hyperglycemia). After erythromycin (T = 20 to T = 80), the frequency (p < 0.05) and amplitude (p < 0.01) of antral waves were less during hyperglycemia than euglycemia. Both propagated (p < 0.0005) and nonpropagated (p < 0.01) antral waves were decreased by hyperglycemia, but the suppression of propagated waves was greater (p < 0.05). Erythromycin reduced the frequency (p = 0.09) but increased the amplitude (p < 0.05) of phasic pyloric pressures, and decreased basal pyloric pressure (p < 0.0005). The frequency (p = 0.06) and amplitude (p < 0.05) of phasic pyloric waves during erythromycin infusion were slightly less during hyperglycemia than euglycemia, whereas there was no effect of the blood glucose concentration on basal pyloric pressure. Erythromycin increased the amplitude (p < 0.001) but not the frequency of duodenal waves; the frequency and amplitude of duodenal waves did not differ between the two blood glucose concentrations.CONCLUSIONS:Hyperglycemia attenuates the stimulation of antral pressures and propagated antral sequences by erythromycin, but not the effects of erythromycin on pyloric or duodenal motility.

Url:
DOI: 10.1016/S0002-9270(00)01042-X


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The stimulation of antral motility by erythromycin is attenuated by hyperglycemia</title>
<author>
<name sortKey="Rayner, C K" sort="Rayner, C K" uniqKey="Rayner C" first="C. K" last="Rayner">C. K Rayner</name>
</author>
<author>
<name sortKey="Su, Y C" sort="Su, Y C" uniqKey="Su Y" first="Y.-C" last="Su">Y.-C Su</name>
</author>
<author>
<name sortKey="Doran, S M" sort="Doran, S M" uniqKey="Doran S" first="S. M" last="Doran">S. M Doran</name>
</author>
<author>
<name sortKey="Jones, K L" sort="Jones, K L" uniqKey="Jones K" first="K. L" last="Jones">K. L Jones</name>
</author>
<author>
<name sortKey="Malbert, C H" sort="Malbert, C H" uniqKey="Malbert C" first="C. H" last="Malbert">C. H Malbert</name>
</author>
<author>
<name sortKey="Horowitz, M" sort="Horowitz, M" uniqKey="Horowitz M" first="M" last="Horowitz">M. Horowitz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1AABB8E93B47CD8CF212597BA37A30ACA32F387B</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S0002-9270(00)01042-X</idno>
<idno type="url">https://api.istex.fr/document/1AABB8E93B47CD8CF212597BA37A30ACA32F387B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000507</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000507</idno>
<idno type="wicri:Area/Istex/Curation">000507</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F60</idno>
<idno type="wicri:doubleKey">0002-9270:2000:Rayner C:the:stimulation:of</idno>
<idno type="wicri:Area/Main/Merge">00CE39</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0468669</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005E02</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000368</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005A55</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005A55</idno>
<idno type="wicri:doubleKey">0002-9270:2000:Rayner C:the:stimulation:of</idno>
<idno type="wicri:Area/Main/Merge">00D003</idno>
<idno type="wicri:Area/Main/Curation">00BF26</idno>
<idno type="wicri:Area/Main/Exploration">00BF26</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The stimulation of antral motility by erythromycin is attenuated by hyperglycemia</title>
<author>
<name sortKey="Rayner, C K" sort="Rayner, C K" uniqKey="Rayner C" first="C. K" last="Rayner">C. K Rayner</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Adelaide Department of Medicine, Royal Adelaide Hospital, Adelaide</wicri:regionArea>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Su, Y C" sort="Su, Y C" uniqKey="Su Y" first="Y.-C" last="Su">Y.-C Su</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Adelaide Department of Medicine, Royal Adelaide Hospital, Adelaide</wicri:regionArea>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Doran, S M" sort="Doran, S M" uniqKey="Doran S" first="S. M" last="Doran">S. M Doran</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Adelaide Department of Medicine, Royal Adelaide Hospital, Adelaide</wicri:regionArea>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jones, K L" sort="Jones, K L" uniqKey="Jones K" first="K. L" last="Jones">K. L Jones</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Adelaide Department of Medicine, Royal Adelaide Hospital, Adelaide</wicri:regionArea>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malbert, C H" sort="Malbert, C H" uniqKey="Malbert C" first="C. H" last="Malbert">C. H Malbert</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Contrôle des Flux Digestifs et Métabolisme Protéique, Station de Recherches Porcines, Institut National de la Recherche Agronomique, Saint-Gilles</wicri:regionArea>
<wicri:noRegion>Saint-Gilles</wicri:noRegion>
<wicri:noRegion>Saint-Gilles</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Horowitz, M" sort="Horowitz, M" uniqKey="Horowitz M" first="M" last="Horowitz">M. Horowitz</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Adelaide Department of Medicine, Royal Adelaide Hospital, Adelaide</wicri:regionArea>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Reprint requests and correspondence: Prof. M. Horowitz, Department of Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000</wicri:regionArea>
<wicri:noRegion>South Australia 5000</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The American Journal of Gastroenterology</title>
<title level="j" type="abbrev">AMGAST</title>
<idno type="ISSN">0002-9270</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">95</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="2233">2233</biblScope>
<biblScope unit="page" to="2241">2241</biblScope>
</imprint>
<idno type="ISSN">0002-9270</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0002-9270</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Acute hyperglycemia</term>
<term>Adelaide</term>
<term>Antagonism</term>
<term>Antral</term>
<term>Antral motility</term>
<term>Antral pressure waves</term>
<term>Antral waves</term>
<term>Antrum</term>
<term>Antrum pyloricum</term>
<term>Attenuates</term>
<term>Basal</term>
<term>Basal pyloric pressure</term>
<term>Basal pyloric pressures</term>
<term>Biological activity</term>
<term>Blood glucose concentration</term>
<term>Blood glucose concentrations</term>
<term>Chemotherapy</term>
<term>Cholinergic</term>
<term>Cisapride</term>
<term>Complication</term>
<term>Diabetes mellitus</term>
<term>Diabetic gastroparesis</term>
<term>Duodenal</term>
<term>Duodenal motility</term>
<term>Duodenal pressure waves</term>
<term>Duodenal sideholes</term>
<term>Duodenal waves</term>
<term>Duodenum</term>
<term>Erythromycin</term>
<term>Erythromycin infusion</term>
<term>Euglycemia</term>
<term>Experimental study</term>
<term>Fasting</term>
<term>Fasting period</term>
<term>Fraser</term>
<term>Gastric</term>
<term>Gastroenterol</term>
<term>Gastroenterology</term>
<term>Gastrointestinal paresis</term>
<term>Gastrokinetic</term>
<term>Gastrokinetic effects</term>
<term>Gastroparesis</term>
<term>Glucose</term>
<term>Healthy subject</term>
<term>Healthy subjects</term>
<term>Higher doses</term>
<term>Human</term>
<term>Hyperglycemia</term>
<term>Hyperglycemia attenuates</term>
<term>Infusion</term>
<term>Insulin dependent diabetes</term>
<term>Intraduodenal</term>
<term>Intraduodenal lipid infusion</term>
<term>Intravenous</term>
<term>Intravenous erythromycin</term>
<term>Lipid</term>
<term>Macrolide</term>
<term>Mellitus</term>
<term>Motilin</term>
<term>Motility</term>
<term>Normal subjects</term>
<term>Phasic</term>
<term>Physiol</term>
<term>Prokinetic</term>
<term>Prokinetic agent</term>
<term>Prokinetic agents</term>
<term>Pyloric</term>
<term>Pyloric pressure waves</term>
<term>Pylorus</term>
<term>Rayner</term>
<term>Sideholes</term>
<term>Sleeve sensor</term>
<term>Smooth muscle</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Activité biologique</term>
<term>Antagonisme</term>
<term>Antre pylorique</term>
<term>Chimiothérapie</term>
<term>Complication</term>
<term>Diabète insulinodépendant</term>
<term>Erythromycine</term>
<term>Etude expérimentale</term>
<term>Homme</term>
<term>Hyperglycémie</term>
<term>Individu sain</term>
<term>Macrolide</term>
<term>Parésie gastrointestinale</term>
<term>Prokinétique</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acute hyperglycemia</term>
<term>Adelaide</term>
<term>Antral</term>
<term>Antral motility</term>
<term>Antral pressure waves</term>
<term>Antral waves</term>
<term>Antrum</term>
<term>Attenuates</term>
<term>Basal</term>
<term>Basal pyloric pressure</term>
<term>Basal pyloric pressures</term>
<term>Blood glucose concentration</term>
<term>Blood glucose concentrations</term>
<term>Cholinergic</term>
<term>Cisapride</term>
<term>Diabetes mellitus</term>
<term>Diabetic gastroparesis</term>
<term>Duodenal</term>
<term>Duodenal motility</term>
<term>Duodenal pressure waves</term>
<term>Duodenal sideholes</term>
<term>Duodenal waves</term>
<term>Duodenum</term>
<term>Erythromycin</term>
<term>Erythromycin infusion</term>
<term>Euglycemia</term>
<term>Fasting</term>
<term>Fasting period</term>
<term>Fraser</term>
<term>Gastric</term>
<term>Gastroenterol</term>
<term>Gastroenterology</term>
<term>Gastrokinetic</term>
<term>Gastrokinetic effects</term>
<term>Gastroparesis</term>
<term>Glucose</term>
<term>Healthy subjects</term>
<term>Higher doses</term>
<term>Hyperglycemia</term>
<term>Hyperglycemia attenuates</term>
<term>Infusion</term>
<term>Intraduodenal</term>
<term>Intraduodenal lipid infusion</term>
<term>Intravenous</term>
<term>Intravenous erythromycin</term>
<term>Lipid</term>
<term>Mellitus</term>
<term>Motilin</term>
<term>Motility</term>
<term>Normal subjects</term>
<term>Phasic</term>
<term>Physiol</term>
<term>Prokinetic</term>
<term>Prokinetic agents</term>
<term>Pyloric</term>
<term>Pyloric pressure waves</term>
<term>Pylorus</term>
<term>Rayner</term>
<term>Sideholes</term>
<term>Sleeve sensor</term>
<term>Smooth muscle</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Glucose</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: OBJECTIVE:Diabetic gastroparesis is usually treated with prokinetic drugs, of which the most potent, when given intravenously during euglycemia, is erythromycin. Recent studies have demonstrated that the gastrokinetic effects of erythromycin are attenuated by hyperglycemia. The aim of this study was to determine whether the effects of erythromycin on antropyloroduodenal motility, including the organization of antral pressure waves, are modified by hyperglycemia.METHODS:A total of eight healthy male volunteers (median age 24 yr) were studied on 2 days each in randomized order. A manometric assembly, incorporating six antral, two pyloric, and seven duodenal sideholes and a pyloric sleeve sensor, was positioned with the sleeve spanning the pylorus. The blood glucose concentration was stabilized at about 5 mmol/L (euglycemia) or 15 mmol/L (hyperglycemia). After 30 min (T = 0), an intraduodenal lipid infusion (1.5 kcal/min) was commenced and continued until the end of the study. At T = 20 minutes, erythromycin (200 mg) as the lactobionate was infused intravenously over 20 min, followed by 100 mg over the next 40 min.RESULTS:Intravenous erythromycin increased the amplitude of antral waves during intraduodenal lipid infusion at both blood glucose concentrations (p < 0.01 for euglycemia and p < 0.05 for hyperglycemia). After erythromycin (T = 20 to T = 80), the frequency (p < 0.05) and amplitude (p < 0.01) of antral waves were less during hyperglycemia than euglycemia. Both propagated (p < 0.0005) and nonpropagated (p < 0.01) antral waves were decreased by hyperglycemia, but the suppression of propagated waves was greater (p < 0.05). Erythromycin reduced the frequency (p = 0.09) but increased the amplitude (p < 0.05) of phasic pyloric pressures, and decreased basal pyloric pressure (p < 0.0005). The frequency (p = 0.06) and amplitude (p < 0.05) of phasic pyloric waves during erythromycin infusion were slightly less during hyperglycemia than euglycemia, whereas there was no effect of the blood glucose concentration on basal pyloric pressure. Erythromycin increased the amplitude (p < 0.001) but not the frequency of duodenal waves; the frequency and amplitude of duodenal waves did not differ between the two blood glucose concentrations.CONCLUSIONS:Hyperglycemia attenuates the stimulation of antral pressures and propagated antral sequences by erythromycin, but not the effects of erythromycin on pyloric or duodenal motility.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
</country>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Rayner, C K" sort="Rayner, C K" uniqKey="Rayner C" first="C. K" last="Rayner">C. K Rayner</name>
</noRegion>
<name sortKey="Doran, S M" sort="Doran, S M" uniqKey="Doran S" first="S. M" last="Doran">S. M Doran</name>
<name sortKey="Horowitz, M" sort="Horowitz, M" uniqKey="Horowitz M" first="M" last="Horowitz">M. Horowitz</name>
<name sortKey="Horowitz, M" sort="Horowitz, M" uniqKey="Horowitz M" first="M" last="Horowitz">M. Horowitz</name>
<name sortKey="Jones, K L" sort="Jones, K L" uniqKey="Jones K" first="K. L" last="Jones">K. L Jones</name>
<name sortKey="Su, Y C" sort="Su, Y C" uniqKey="Su Y" first="Y.-C" last="Su">Y.-C Su</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Malbert, C H" sort="Malbert, C H" uniqKey="Malbert C" first="C. H" last="Malbert">C. H Malbert</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BF26 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00BF26 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:1AABB8E93B47CD8CF212597BA37A30ACA32F387B
   |texte=   The stimulation of antral motility by erythromycin is attenuated by hyperglycemia
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024